Intelligent Bio Solutions Inventory 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions inventory from 2020 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions inventory from 2020 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$146B
CVS Health (CVS)	$90.6B
Elevance Health (ELV)	$69.7B
Cencora (COR)	$58.8B
DiDi Global (DIDIY)	$29.4B
Labcorp Holdings (LH)	$23B
Natera (NTRA)	$22.2B
BioMerieux (BMXMF)	$17.5B
EUROFINS SCIENT (ERFSF)	$15.5B
ICON (ICLR)	$14.2B
Medpace Holdings (MEDP)	$12.7B
CochLear (CHEOY)	$12.7B
Solventum (SOLV)	$12.5B
Viatris (VTRS)	$12.5B
Caris Life Sciences,�Inc (CAI)	$10.7B
Revvity (RVTY)	$10.4B
Avantor (AVTR)	$8.6B
Sonic Healthcare (SKHHY)	$8B
HealthEquity (HQY)	$7.9B
Charles River Laboratories (CRL)	$7.6B
Bausch + Lomb (BLCO)	$5.1B
Sotera Health (SHC)	$4.5B
BrightSpring Health Services (BTSG)	$4.2B
KindlyMD (NAKA)	$4B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.5B
Alignment Healthcare (ALHC)	$3.1B
Concentras Parent (CON)	$2.9B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.4B